Reuters logo
BRIEF-‍Immunocore receives investment from Bill & Melinda Gates Foundation
September 18, 2017 / 11:20 AM / 3 months ago

BRIEF-‍Immunocore receives investment from Bill & Melinda Gates Foundation

Sept 18 (Reuters) - ‍Immunocore

* Immunocore - announced investment from Bill & Melinda Gates Foundation for development of soluble TCR-based therapeutics for infectious diseases​

* Immunocore Limited says the Bill & Melinda gates foundation will invest up to $40 million in​ co Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below